Between 2013 and 2023, antibacterial medicine sales in Belgium experienced a declining trend, starting at $290.7 million in 2013 and dropping to $209.0 million in 2023. The year-on-year variation was notably negative with occasional minor rebounds, such as in 2018 and 2021. The most significant drop occurred between 2015 and 2016. Over the last five years, the average annual decline was around 1.06%. Future projections indicate a continued decrease, averaging a 1.78% annual decline up to 2028, marking an 8.6% total reduction.
Future trends to watch for include:
• Emerging antibacterial resistance impacting demand.
• Regulatory changes pushing for alternative treatments.
• Technological advances in medicine potentially leading to new product introductions.
